Evidence map›Paper›PMID 29279491›Full record

ReviewInternal medicine (Tokyo, Japan)2018

IgG4-related Disease - A Systemic Disease that Deserves Attention Regardless of One's Subspecialty.

Hideaki Hamano, Eiji Tanaka, Nobukazu Ishizaka, Shigeyuki Kawa

Abstract readReview
In one paragraph

Review in Internal medicine (Tokyo, Japan), 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed.

  1. Article
  2. Thoracic involvement and imaging patterns in IgG4-related disease.European respiratory review : an official journal of the European Respiratory Society · 2021
    Review
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Immunoglobulin G4-related disease in a dog.Journal of veterinary internal medicine · 2019
    Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Hideaki HamanoDivision of Medical Informatics, Shinshu University Hospital, Japan.
Eiji TanakaDepartment of Internal Medicine, Gastroenterology, Shinshu University School of Medicine, Japan.
Nobukazu IshizakaDepartment of Cardiology, Osaka Medical College, Japan.
Shigeyuki KawaDepartment of Internal Medicine, Matsumoto Dental University, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

IgG4-related disease (IgG4-RD) is an inflammatory condition characterized by a high serum IgG4 concentration and the abundant infiltration of lymphocytes and IgG4-positive plasma cells in the tissue, as well as spatial (diverse clinical manifestations) and temporal (the possibility of recurrence) multiplicities. Since the initial documentation of IgG4-related disease in patients with autoimmune pancreatitis in 2001, a growing body of evidence has been accumulating to suggest that various-virtually all-organs can be affected by IgG4-RD. In general, steroid therapy is effective and is considered to be the first-line treatment for IgG4-RD. The precise mechanism underlying this systemic disorder has remained unknown. Considering that IgG4-RD was specified as being an intractable disease in 2015, further studies are needed to clarify whether IgG4-RD is indeed a distinct disease entity or a complex of disorders of different etiologies and clinical conditions.

Indexed as

Adrenal Cortex HormonesAutoimmune DiseasesHumansImmunoglobulin GPancreatitisRecurrenceAdrenal Cortex HormonesImmunoglobulin Gautoimmune pancreatitisIgG4-related disease

Identifiers

PMID29279491
PMCPMC5980798

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.